Tachicardia-induced cardiomyopathy. Case report

Maria R. Atabegashvili; Атабегашвили Мария Рубеновна; Dmitry Yu. Shchekochikhin; Щекочихин Дмитрий Юрьевич; Grigory A. Gromyko; Громыко Григорий Алексеевич; Ekaterina S. Pershina; Першина Екатерина Сергеевна; Alexandra A. Bogdanova; Богданова Александра Андреевна; Alexey P. Nesterov; Нестеров Алексей Петрович; Alexandra S. Shilova; Шилова Александра Сергеевна; Mihail Yu. Gilyarov; Гиляров Михаил Юрьевич; Alexey V. Svet; Свет Алексей Викторович

doi:10.26442/00403660.2021.04.200803

Tachicardia-induced cardiomyopathy. Case report

Authors: Atabegashvili M.R.¹, Shchekochikhin D.Y.¹^,2^,3, Gromyko G.A.⁴, Pershina E.S.¹, Bogdanova A.A.¹^,3, Nesterov A.P.¹^,3, Shilova A.S.¹^,3, Gilyarov M.Y.¹^,2^,3, Svet A.V.¹^,2
Affiliations:
1. Pirogov City Clinical Hospital №1
2. Sechenov First Moscow State Medical University (Sechenov University)
3. Pirogov Russian National Research Medical University
4. Vishnevsky 3 Central Military Clinical Hospital
Issue: Vol 93, No 4 (2021)
Pages: 465-469
Section: Clinical notes
URL: https://journals.rcsi.science/0040-3660/article/view/71250
DOI: https://doi.org/10.26442/00403660.2021.04.200803
ID: 71250

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The tachycardia-induced cardiomyopathy is a rare case of reversible heart failure and left ventricle disfunction. The diagnostic approach and treatment strategy are described in this article. Also the clinical case of heart failure compensation in the patient with left ventricle dilatation and atrial flutter after the reverse to sinus rhythm is after catheter ablation presented.

Keywords

tachycardia-induced cardiomyopathy, heart failure, atrial flutter, catheter ablation

Full Text

##article.viewOnOriginalSite##

About the authors

Maria R. Atabegashvili

Pirogov City Clinical Hospital №1

Author for correspondence.
Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-2420-6543

врач-кардиолог

Russian Federation, Moscow

Dmitry Yu. Shchekochikhin

Pirogov City Clinical Hospital №1; Sechenov First Moscow State Medical University (Sechenov University); Pirogov Russian National Research Medical University

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-8209-2791

к.м.н., врач-кардиолог ГБУЗ «ГКБ №1 им Н.И. Пирогова», доц. каф. профилактической и неотложной кардиологии лечебного фак-та, рук. научно-исследовательского отд. кардиологии ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет), доц. каф. интервенционной кардиологии и кардиореабилитации ФДПО ФГАОУ ВО «РНИМУ им. Н.И. Пирогова».

Russian Federation, Moscow

Grigory A. Gromyko

Vishnevsky 3 Central Military Clinical Hospital

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-7942-9795

к.м.н, зав. отд. кардиохирургии (хирургического лечения нарушений ритма сердца)

Russian Federation, Krasnogorsk

Ekaterina S. Pershina

Pirogov City Clinical Hospital №1

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-3952-6865

к.м.н, рук. центра лучевой диагностики

Russian Federation, Moscow

Alexandra A. Bogdanova

Pirogov City Clinical Hospital №1; Pirogov Russian National Research Medical University

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0001-5509-8023

к.м.н, доц., зав. отд. функциональной диагностики ГБУЗ «ГКБ №1 им. Н.И. Пирогова», каф. интервенционной кардиологии и кардиореабилитации ФГАОУ ВО «РНИМУ им. Н.И. Пирогова»

Russian Federation, Moscow

Alexey P. Nesterov

Pirogov City Clinical Hospital №1; Pirogov Russian National Research Medical University

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-5602-8809

к.м.н, доц., рук. Регионального сосудистого центра ГБУЗ «ГКБ №1 им. Н.И. Пирогова», каф. интервенционной кардиологии и кардиореабилитации ФГАОУ ВО «РНИМУ им. Н.И. Пирогова»

Russian Federation, Moscow

Alexandra S. Shilova

Pirogov City Clinical Hospital №1; Pirogov Russian National Research Medical University

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-4092-5222

к.м.н., зав. 15-м отд-нием реанимации и интенсивной терапии ГБУЗ «ГКБ №1 им Н.И. Пирогова», доц. каф. интервенционной кардиологии и кардиореабилитации ФДПО ФГАОУ ВО «РНИМУ им. Н.И. Пирогова»

Russian Federation, Moscow

Mihail Yu. Gilyarov

Pirogov City Clinical Hospital №1; Sechenov First Moscow State Medical University (Sechenov University); Pirogov Russian National Research Medical University

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-2870-3301

д.м.н., проф., зам. глав. врача, зав. кафедрой ГБУЗ «ГКБ №1 им. Н.И. Пирогова», каф. профилактической и неотложной кардиологии ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет), каф. интервенционной кардиологии и кардиореабилитации ФГАОУ ВО «РНИМУ им. Н.И. Пирогова»

Russian Federation, Moscow

Alexey V. Svet

Pirogov City Clinical Hospital №1; Sechenov First Moscow State Medical University (Sechenov University)

Email: maria.atabegashvili@hotmail.com
ORCID iD: 0000-0002-2278-7292

к.м.н., глав. врач ГБУЗ «ГКБ №1 им Н.И. Пирогова», доц. каф. кардиологии, функциональной и ультразвуковой диагностики ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)

Russian Federation, Moscow

References

Mohamed H. Tachycardia-Induced Cardiomyopathy (Tachycardiomyopathy). Libyan J Med. 2007;2(1):26-9. doi: 10.4176/061226
Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease. Am J Med. 1949;7(4):478-89. doi: 10.1016/0002-9343(49)90397-6
Greenberg BH. The Medical Management of Chronic Congestive Heart Failure. Congestive Heart Failure. 1994:628-44. doi: 10.1007/978-1-4613-8315-4_34
Gopinathannair R, Etheridge SP, Marchlinski FE, et al. Arrhythmia-Induced Cardiomyopathies. J Am Coll Cardiol. 2015;66(15):1714-28. doi: 10.1016/j.jacc.2015.08.038
Cruz FES, Cheriex EC, Smeets JLRM, et al. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol. 1990;16(3):739-44. doi: 10.1016/0735-1097(90)90368-y
Brembilla-Perrot B, Ferreira JP, Manenti V, et al. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation. Eur J Heart Fail. 2016;18(4):394-401. doi: 10.1002/ejhf.482
Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17):2160-72. doi: 10.1016/j.jacc.2017.02.049
Jeong Y-H, Choi K-J, Song J-M, et al. Diagnostic Approach and Treatment Strategy in Tachycardia-induced Cardiomyopathy. Clin Cardiol. 2008;31(4):172-8. doi: 10.1002/clc.20161
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developedin collaboration with eacts. Russian Journal of Cardiology. 2017;(7):7-86. doi: 10.15829/1560-4071-2017-7-7-86
Packer DL, Mark DB, Robb RA, et al. Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design. Am Heart J. 2018;199:192-9. doi: 10.1016/j.ahj.2018.02.015
Marrouche NF, Brachmann J, Andresen D, et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378(5):417-27. doi: 10.1056/NEJMoa1707855